CYPHERPUNK TECHNOLOGIES INC. Operating Cash Flow
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Operating Cash Flow of -$6.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.69M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.43M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.62M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.32M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2025 was -$43.90M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2024 was -$60.30M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2023 was -$43.75M.
- CYPHERPUNK TECHNOLOGIES INC. net cash provided by (used in) operating activities for fiscal 2022 was -$49.04M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$6.12M 10-Q · filed 2026-08-12 | -$12.74M derived: sum of 3 quarters · filed 2026-08-12 | -$21.06M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$3.43M 10-Q · filed 2026-05-14 | -$10.05M derived: sum of 2 quarters · filed 2026-05-14 | -$18.37M derived: sum of 3 quarters · filed 2026-05-14 | -$32.85M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$6.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$14.94M derived: sum of 2 quarters · filed 2026-03-16 | -$29.42M derived: sum of 3 quarters · filed 2026-08-12 | -$43.90M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$8.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$22.80M derived: sum of 2 quarters · filed 2026-08-12 | -$37.28M 10-Q · filed 2025-11-12 | -$52.80M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$14.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$28.97M 10-Q · filed 2026-08-12 | -$44.48M derived: sum of 3 quarters · filed 2026-08-12 | -$60.08M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$14.48M 10-Q · filed 2026-05-14 | -$29.99M derived: sum of 2 quarters · filed 2026-05-14 | -$45.59M derived: sum of 3 quarters · filed 2026-05-14 | -$59.26M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$15.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$31.11M derived: sum of 2 quarters · filed 2026-03-16 | -$44.78M derived: sum of 3 quarters · filed 2026-03-16 | -$60.30M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$15.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$29.27M derived: sum of 2 quarters · filed 2025-11-12 | -$44.79M 10-Q · filed 2025-11-12 | -$55.17M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$13.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$29.19M 10-Q · filed 2025-08-14 | -$39.57M derived: sum of 3 quarters · filed 2025-08-14 | -$50.05M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$15.52M 10-Q · filed 2025-05-13 | -$25.90M derived: sum of 2 quarters · filed 2025-05-13 | -$36.38M derived: sum of 3 quarters · filed 2025-05-13 | -$46.57M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$20.87M derived: sum of 2 quarters · filed 2025-03-26 | -$31.05M derived: sum of 3 quarters · filed 2025-03-26 | -$43.75M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$10.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$20.67M derived: sum of 2 quarters · filed 2024-11-13 | -$33.37M 10-Q · filed 2024-11-13 | -$46.39M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$10.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$22.89M 10-Q · filed 2024-08-12 | -$35.90M derived: sum of 3 quarters · filed 2024-08-12 | -$48.15M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$12.70M 10-Q · filed 2024-05-13 | -$25.71M derived: sum of 2 quarters · filed 2024-05-13 | -$37.97M derived: sum of 3 quarters · filed 2024-05-13 | -$50.23M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$25.27M derived: sum of 2 quarters · filed 2024-03-18 | -$37.53M derived: sum of 3 quarters · filed 2024-03-18 | -$49.04M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$12.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$24.51M derived: sum of 2 quarters · filed 2023-11-13 | -$36.03M 10-Q · filed 2023-11-13 | -$46.75M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$12.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$23.78M 10-Q · filed 2023-08-14 | -$34.49M derived: sum of 3 quarters · filed 2023-08-14 | -$42.59M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$11.52M 10-Q · filed 2023-05-15 | -$22.23M derived: sum of 2 quarters · filed 2023-05-15 | -$30.34M derived: sum of 3 quarters · filed 2023-05-15 | -$38.09M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$10.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$18.82M derived: sum of 2 quarters · filed 2023-03-24 | -$26.57M derived: sum of 3 quarters · filed 2023-03-24 | -$35.16M 10-K · filed 2023-03-24 |
| 2021-09-30 | -$8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$15.85M derived: sum of 2 quarters · filed 2022-11-14 | -$24.44M 10-Q · filed 2022-11-14 | -$30.43M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$7.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$16.34M 10-Q · filed 2022-08-12 | -$22.33M derived: sum of 3 quarters · filed 2022-08-12 | -$28.92M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$8.59M 10-Q · filed 2022-05-13 | -$14.57M derived: sum of 2 quarters · filed 2022-05-13 | -$21.17M derived: sum of 3 quarters · filed 2022-05-13 | -$30.62M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$12.58M derived: sum of 2 quarters · filed 2022-03-11 | -$22.03M derived: sum of 3 quarters · filed 2022-03-11 | -$25.96M 10-K · filed 2022-03-11 |
| 2020-09-30 | -$6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$16.04M derived: sum of 2 quarters · filed 2021-11-12 | -$19.97M 10-Q · filed 2021-11-12 | -$25.86M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$9.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$13.38M 10-Q · filed 2021-08-13 | -$19.27M derived: sum of 3 quarters · filed 2021-08-13 | -$26.23M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$3.93M 10-Q · filed 2021-05-14 | -$9.82M derived: sum of 2 quarters · filed 2021-05-14 | -$16.78M derived: sum of 3 quarters · filed 2021-05-14 | -$23.96M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$12.85M derived: sum of 2 quarters · filed 2021-03-12 | -$20.03M derived: sum of 3 quarters · filed 2021-03-12 | -$26.90M 10-K · filed 2021-03-12 |
| 2019-09-30 | -$6.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$14.14M derived: sum of 2 quarters · filed 2020-11-12 | -$21.01M 10-Q · filed 2020-11-12 | -$28.06M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$14.05M 10-Q · filed 2020-08-13 | -$21.10M derived: sum of 3 quarters · filed 2020-08-13 | -$28.55M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$6.87M 10-Q · filed 2020-05-14 | -$13.92M derived: sum of 2 quarters · filed 2020-05-14 | -$21.37M derived: sum of 3 quarters · filed 2020-05-14 | -$27.42M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$14.50M derived: sum of 2 quarters · filed 2020-03-16 | -$20.55M derived: sum of 3 quarters · filed 2020-03-16 | -$26.03M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$7.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$13.51M derived: sum of 2 quarters · filed 2019-11-14 | -$18.98M 10-Q · filed 2019-11-14 | -$25.35M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$6.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$11.53M 10-Q · filed 2019-08-09 | -$17.90M derived: sum of 3 quarters · filed 2019-08-09 | -$20.26M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$5.48M 10-Q · filed 2019-05-15 | -$11.85M derived: sum of 2 quarters · filed 2019-05-15 | -$14.20M derived: sum of 3 quarters · filed 2019-05-15 | -$21.27M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$8.73M derived: sum of 2 quarters · filed 2019-04-01 | -$15.79M derived: sum of 3 quarters · filed 2019-04-01 | -$22.14M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$9.42M derived: sum of 2 quarters · filed 2018-11-09 | -$15.77M 10-Q · filed 2018-11-09 | -$23.07M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$7.06M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | -$13.41M 10-Q · filed 2018-08-08 | -$20.71M derived: sum of 3 quarters · filed 2018-08-08 | -$28.08M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$6.35M 10-Q/A · filed 2018-08-08 | -$13.65M derived: sum of 2 quarters · filed 2018-08-08 | -$21.02M derived: sum of 3 quarters · filed 2018-08-08 | |
| 2016-12-31 | -$7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$14.67M derived: sum of 2 quarters · filed 2018-02-23 | -$25.34M 10-K · filed 2018-02-23 | |
| 2016-09-30 | -$7.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$18.04M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | -$10.67M 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |